We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Apotex Loses Battle With Daiichi Over Ear-Drop Patent

Law360 (August 3, 2006, 12:00 AM EDT) -- A New Jersey district court has rejected Apotex Inc.’s generic challenge to Daiichi Sankyo Co.’s Floxin Otic, handing the Japanese pharmaceutical giant a crucial victory in the long-simmering patent brawl over the groundbreaking ear-drop medicine.

Judge William G. Bassler of the U.S. District Court for the District of New Jersey granted Daiichi’s request for summary judgment, ruling that its method-of-treatment patent is valid and enforceable and was infringed by the Canadian manufacturer's generic product.

Daiichi confirmed the news on Thursday, revealing in a filing with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.